\
&
Contact us
\
&
Contact us
Published on | 1 month ago
ProgrammesThe fourth and final call of the FRONTIERS Science Journalism Residency Programme is open for applications. Up to ten early career-journalists (up to 5 years of professional experience), mid-career (6 to 9 years of experience), and established (10+ years of experience) can be supported by a grant of up to €6000 per month, for a period of minimum three up to five months. The call deadline for the FRONTIERS Science Journalism Residency Program Round 4 is 25 May 2025, 17.00 (CEST).
All information on the fourth call i.e. programme objectives, eligibility criteria, application and evaluation procedure, financial support, Residency Program Guide and FAQs can be found on the dedicated webpage on the FRONTIERS website. The recording of the info day on the third call and previous calls is available on FRONTIERS YouTube Channel @FRONTIERS_media.
What is FRONTIERS?
FRONTIERS is the science journalism initiative funded by the European Research Council (ERC) to design a residency programme for science journalists wishing to experience an immersive period in a European research institution.
The FRONTIERS project is set to run from 2023 to 2027. During this time, the FRONTIERS team plans four calls to enable up to 40 science journalists to spend time with research teams, working on their own reporting ideas at institutions of their choice. Fellows and residency projects from previous rounds can be consulted here.
While backing independent science journalism, FRONTIERS hopes to contribute to the public trust in scientific institutions and in the scientific method itself, to ensure European citizens have access to reliable and accurate scientific reporting, to tackle misinformation and disinformation, ultimately contributing to more informed policymaking and a more scientifically literate society.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital Europe AI Continent Advanced Digital Skills Deployment: Best use of technologies
The European Commission has published a new round of calls under the Digital Europe programme. The submission period for the following call topics will open on 21 April 2026: Apply AI: Piloting AI-based image screening in medical centres Digital solutions for regulatory compliance through data Advanced Digital Skills for AI Uptake in Health... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
